CA
GILD icon

Calton & Associates’s Gilead Sciences GILD Stock Holding History

Calton & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,038
Closed -$284K – 439
2026
Q1 		$284K Buy
2,038
+6
+0.3% +$840 0.04% 331
2025
Q4 		$249K Buy
2,032
+64
+3% +$7.78K 0.04% 374
2025
Q3 		$218K Buy
1,968
+16
+0.8% +$1.82K 0.03% 385
2025
Q2 		$216K Buy
+1,952
New +$208K 0.04% 352
2021
Q4 		– Sell
-3,958
Closed -$276K – 378
2021
Q3 		$276K Sell
3,958
-204
-5% -$14.3K 0.06% 304
2021
Q2 		$287K Buy
4,162
+633
+18% +$42.3K 0.05% 308
2021
Q1 		$228K Sell
3,529
-92
-3% -$5.93K 0.04% 350
2020
Q4 		$211K Sell
3,621
-1,996
-36% -$120K 0.04% 357
2020
Q3 		$355K Buy
5,617
+1,022
+22% +$70.9K 0.07% 208
2020
Q2 		$354K Sell
4,595
-2,646
-37% -$203K 0.08% 196
2020
Q1 		$541K Sell
7,241
-1,435
-17% -$99.2K 0.13% 136
2019
Q4 		$564K Buy
8,676
+1,588
+22% +$103K 0.11% 159
2019
Q3 		$449K Sell
7,088
-397
-5% -$26K 0.1% 168
2019
Q2 		$506K Sell
7,485
-465
-6% -$30.6K 0.14% 124
2019
Q1 		$517K Sell
7,950
-401
-5% -$26.7K 0.16% 125
2018
Q4 		$522K Sell
8,351
-30
-0.4% -$2.1K 0.19% 105
2018
Q3 		$647K Sell
8,381
-6
-0.1% -$453 0.19% 99
2018
Q2 		$645K Sell
8,387
-1,684
-17% -$119K 0.19% 92
2018
Q1 		$759K Buy
10,071
+307
+3% +$24.4K 0.22% 94
2017
Q4 		$790K Buy
+9,764
New +$741K 0.2% 93

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Calton & Associates's GILD Position: Q2 2026 in Review

Calton & Associates sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,038 shares — an estimated $284K sold.

Calton & Associates first reported a position in GILD in Q4 2017 and held it in 20 quarters. The position peaked at $790K in Q4 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Calton & Associates reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Calton & Associates sold 2,038 Gilead Sciences shares in Q2 2026, an estimated $284K.
  • Calton & Associates first reported a position in Gilead Sciences in Q4 2017 and held it in 20 quarters.
  • Calton & Associates's Gilead Sciences position peaked at $790K in Q4 2017.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.